{"id":737,"date":"2020-08-03T08:00:20","date_gmt":"2020-08-03T08:00:20","guid":{"rendered":"http:\/\/immunologik.de\/?p=737"},"modified":"2020-10-05T13:11:36","modified_gmt":"2020-10-05T13:11:36","slug":"start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest","status":"publish","type":"post","link":"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/","title":{"rendered":"Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de"},"content":{"rendered":"<p>In the fight against coronaviruses the team of the ImmunoLogik identified a promising lead candidate for the treatment of people infected with SARS-CoV-2. The highly qualified ImmunoLogik Team around Dr. Christian Setz (Managing Director, formerly project leader at the Institute for Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nuremberg) and the scientific advisor Prof. Dr. Ulrich Schubert (Professor for virology at the Institute for Clinical and Molecular Virology, Friedrich-Alexander-University Erlangen-Nuremberg) present this funding project on aescuvest.de in summer 2020. Only here you have the chance to learn more about the concept, to use the information advantage and to become an investor.<br \/>\n<!--more--><br \/>\nLearn more &#038; secure the early-investor bonus on <a href=\"http:\/\/www.aescuvest.de\/immunologik2020\" rel=\"noopener\" target=\"_blank\">www.aescuvest.de\/immunologik2020<\/a><\/p>\n<div style=\"padding:56.25% 0 0 0;position:relative;\"><iframe src=\"https:\/\/player.vimeo.com\/video\/434268297?title=0&#038;byline=0&#038;portrait=0\" style=\"position:absolute;top:0;left:0;width:100%;height:100%;\" frameborder=\"0\" allow=\"autoplay; fullscreen\" allowfullscreen><\/iframe><\/div>\n<p><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><br \/>\nWarning: This investment carries considerable risks and may lead to a complete loss of the assets invested.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the fight against coronaviruses the team of the ImmunoLogik identified a promising lead candidate for the treatment of people infected with SARS-CoV-2. The highly&#8230;<\/p>\n<p class=\"readmore\"><a class=\"more-btn\" href=\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/\">Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":688,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.9.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de | ImmunoLogik<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de | ImmunoLogik\" \/>\n<meta property=\"og:description\" content=\"In the fight against coronaviruses the team of the ImmunoLogik identified a promising lead candidate for the treatment of people infected with SARS-CoV-2. The highly...Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/\" \/>\n<meta property=\"og:site_name\" content=\"ImmunoLogik\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.linkedin.com\/company\/immunologik\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-03T08:00:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-05T13:11:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/immunologik.de\/wp-content\/uploads\/2017\/10\/Imm-LP1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Webmaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Webmaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/\"},\"author\":{\"name\":\"Webmaster\",\"@id\":\"https:\/\/immunologik.de\/en\/#\/schema\/person\/4ba7cd49cd5bab3a9cb85aa2457f2887\"},\"headline\":\"Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de\",\"datePublished\":\"2020-08-03T08:00:20+00:00\",\"dateModified\":\"2020-10-05T13:11:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/\"},\"wordCount\":137,\"publisher\":{\"@id\":\"https:\/\/immunologik.de\/en\/#organization\"},\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/\",\"url\":\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/\",\"name\":\"Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de | ImmunoLogik\",\"isPartOf\":{\"@id\":\"https:\/\/immunologik.de\/en\/#website\"},\"datePublished\":\"2020-08-03T08:00:20+00:00\",\"dateModified\":\"2020-10-05T13:11:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/immunologik.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/immunologik.de\/en\/#website\",\"url\":\"https:\/\/immunologik.de\/en\/\",\"name\":\"ImmunoLogik\",\"description\":\"Forschung &amp; Fortschritt im Kampf gegen Viren\",\"publisher\":{\"@id\":\"https:\/\/immunologik.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/immunologik.de\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/immunologik.de\/en\/#organization\",\"name\":\"ImmunoLogik GmbH\",\"url\":\"https:\/\/immunologik.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/immunologik.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/immunologik.de\/wp-content\/uploads\/2017\/10\/logo-immunologik-web.jpg\",\"contentUrl\":\"http:\/\/immunologik.de\/wp-content\/uploads\/2017\/10\/logo-immunologik-web.jpg\",\"width\":287,\"height\":67,\"caption\":\"ImmunoLogik GmbH\"},\"image\":{\"@id\":\"https:\/\/immunologik.de\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/immunologik\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/immunologik.de\/en\/#\/schema\/person\/4ba7cd49cd5bab3a9cb85aa2457f2887\",\"name\":\"Webmaster\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de | ImmunoLogik","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/","og_locale":"en_US","og_type":"article","og_title":"Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de | ImmunoLogik","og_description":"In the fight against coronaviruses the team of the ImmunoLogik identified a promising lead candidate for the treatment of people infected with SARS-CoV-2. The highly...Read More","og_url":"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/","og_site_name":"ImmunoLogik","article_publisher":"https:\/\/www.linkedin.com\/company\/immunologik\/","article_published_time":"2020-08-03T08:00:20+00:00","article_modified_time":"2020-10-05T13:11:36+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/immunologik.de\/wp-content\/uploads\/2017\/10\/Imm-LP1.jpg","type":"image\/jpeg"}],"author":"Webmaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Webmaster","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/#article","isPartOf":{"@id":"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/"},"author":{"name":"Webmaster","@id":"https:\/\/immunologik.de\/en\/#\/schema\/person\/4ba7cd49cd5bab3a9cb85aa2457f2887"},"headline":"Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de","datePublished":"2020-08-03T08:00:20+00:00","dateModified":"2020-10-05T13:11:36+00:00","mainEntityOfPage":{"@id":"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/"},"wordCount":137,"publisher":{"@id":"https:\/\/immunologik.de\/en\/#organization"},"articleSection":["Business"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/","url":"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/","name":"Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de | ImmunoLogik","isPartOf":{"@id":"https:\/\/immunologik.de\/en\/#website"},"datePublished":"2020-08-03T08:00:20+00:00","dateModified":"2020-10-05T13:11:36+00:00","breadcrumb":{"@id":"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/immunologik.de\/en\/start-der-crowdinvesting-kampagne-gegen-sars-cov-2-bei-aescuvest\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/immunologik.de\/en\/"},{"@type":"ListItem","position":2,"name":"Start of the crowdinvesting campaign against SARS-CoV-2 on aescuvest.de"}]},{"@type":"WebSite","@id":"https:\/\/immunologik.de\/en\/#website","url":"https:\/\/immunologik.de\/en\/","name":"ImmunoLogik","description":"Forschung &amp; Fortschritt im Kampf gegen Viren","publisher":{"@id":"https:\/\/immunologik.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/immunologik.de\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/immunologik.de\/en\/#organization","name":"ImmunoLogik GmbH","url":"https:\/\/immunologik.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/immunologik.de\/en\/#\/schema\/logo\/image\/","url":"http:\/\/immunologik.de\/wp-content\/uploads\/2017\/10\/logo-immunologik-web.jpg","contentUrl":"http:\/\/immunologik.de\/wp-content\/uploads\/2017\/10\/logo-immunologik-web.jpg","width":287,"height":67,"caption":"ImmunoLogik GmbH"},"image":{"@id":"https:\/\/immunologik.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/immunologik\/"]},{"@type":"Person","@id":"https:\/\/immunologik.de\/en\/#\/schema\/person\/4ba7cd49cd5bab3a9cb85aa2457f2887","name":"Webmaster"}]}},"_links":{"self":[{"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/posts\/737"}],"collection":[{"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/comments?post=737"}],"version-history":[{"count":6,"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/posts\/737\/revisions"}],"predecessor-version":[{"id":744,"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/posts\/737\/revisions\/744"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/media\/688"}],"wp:attachment":[{"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/media?parent=737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/categories?post=737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/immunologik.de\/en\/wp-json\/wp\/v2\/tags?post=737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}